Dabrafenib
Product Specifications
CAS Number
1195765-45-7
Target
Raf
Related Pathways
MAPK
Purity
>99.99%
Bioactivity
Dabrafenib (GSK2118436A) is a Raf inhibitor that inhibits C-Raf and B-RafV600E (IC50=5/0.6 nM) and is ATP-competitive. Dabrafenib exhibits antitumor activity for the treatment of B-RafV600E-mutated melanoma.
Smiles
CC(C)(C)c1nc(c(s1)-c1ccnc(N)n1)-c1cccc(NS(=O)(=O)c2c(F)cccc2F)c1F
Molecular Formula
C23H20F3N5O2S2
Molecular Weight
519.56
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
248573-APC 100 µL
MBNL1 (Muscleblind-like (Drosophila), DKFZp686P06174, EXP, EXP35, EXP40, EXP42, KIAA0428, MBNL) (APC)
Sign In for Pricing
View Details 
MBS2038417-01 0.1 mL
APC/CY7-Linked Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)
Sign In for Pricing
View Details MBS2038417-02 0.2 mL
APC/CY7-Linked Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)
Sign In for Pricing
View Details MBS2038417-03 0.5 mL
APC/CY7-Linked Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)
Sign In for Pricing
View Details MBS2038417-04 1 mL
APC/CY7-Linked Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)
Sign In for Pricing
View Details